Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Watanabe

Showing results (651-660 of 687) with videos related to

Pageof 69
Sort By:
Journal of Gastroenterology|May 16, 2026
A modified Delphi consensus on fusion (laparoscopic and robotic) approaches to colorectal surgery in Asia-PacificJun Watanabe, Yoshinori Kagawa, Takashi Nonaka, et al.
Targeted Oncology|January 9, 2024
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal CancerYu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, et al.
The Journal of Molecular Diagnostics : JMD|October 4, 2008
Rapid screening assay for KRAS mutations by the modified smart amplification processKenji Tatsumi, Yasumasa Mitani, Jun Watanabe, et al.
British Journal of Cancer|March 4, 2023
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trialYasutoshi Kuboki, Tetsuji Terazawa, Toshiki Masuishi, et al.
Journal of Neuropathology and Experimental Neurology|November 29, 2020
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated MedulloblastomaManabu Natsumeda, Hiroaki Miyahara, Junichi Yoshimura, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 7, 2025
Quality of life after laparoscopic surgery for very low rectal cancer: A sub-analysis of the ultimate trialHiroki Hamamoto, Keitaro Tanaka, Yuichiro Tsukada, et al.
Annals of Surgery|April 1, 2024
Long-term survival and functional outcomes of laparoscopic surgery for clinical stage I ultra-low rectal cancers located within 5 cm of the anal verge: A prospective phase II trial (Ultimate trial)Masaaki Ito, Yuichiro Tsukada, Jun Watanabe, et al.
The Lancet Regional Health. Western Pacific|May 14, 2023
Optimal bowel resection margin in colon cancer surgery: prospective multicentre cohort study with lymph node and feeding artery mappingHideki Ueno, Kazuo Hase, Akio Shiomi, et al.
Annals of Surgery|September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort StudyKoji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
Diseases of the Colon and Rectum|March 23, 2026
Urinary Function After Laparoscopic Surgery in Very Low Rectal CancerYosuke Fukunaga, Yuichiro Tsukada, Takashi Akiyoshi, et al.
Pageof 69

Showing results (651-660 of 687) with videos related to

Sort By:
Pageof 69
Journal of Gastroenterology|May 16, 2026
A modified Delphi consensus on fusion (laparoscopic and robotic) approaches to colorectal surgery in Asia-PacificJun Watanabe, Yoshinori Kagawa, Takashi Nonaka, et al.
Targeted Oncology|January 9, 2024
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal CancerYu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, et al.
The Journal of Molecular Diagnostics : JMD|October 4, 2008
Rapid screening assay for KRAS mutations by the modified smart amplification processKenji Tatsumi, Yasumasa Mitani, Jun Watanabe, et al.
British Journal of Cancer|March 4, 2023
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trialYasutoshi Kuboki, Tetsuji Terazawa, Toshiki Masuishi, et al.
Journal of Neuropathology and Experimental Neurology|November 29, 2020
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated MedulloblastomaManabu Natsumeda, Hiroaki Miyahara, Junichi Yoshimura, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 7, 2025
Quality of life after laparoscopic surgery for very low rectal cancer: A sub-analysis of the ultimate trialHiroki Hamamoto, Keitaro Tanaka, Yuichiro Tsukada, et al.
Annals of Surgery|April 1, 2024
Long-term survival and functional outcomes of laparoscopic surgery for clinical stage I ultra-low rectal cancers located within 5 cm of the anal verge: A prospective phase II trial (Ultimate trial)Masaaki Ito, Yuichiro Tsukada, Jun Watanabe, et al.
The Lancet Regional Health. Western Pacific|May 14, 2023
Optimal bowel resection margin in colon cancer surgery: prospective multicentre cohort study with lymph node and feeding artery mappingHideki Ueno, Kazuo Hase, Akio Shiomi, et al.
Annals of Surgery|September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort StudyKoji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
Diseases of the Colon and Rectum|March 23, 2026
Urinary Function After Laparoscopic Surgery in Very Low Rectal CancerYosuke Fukunaga, Yuichiro Tsukada, Takashi Akiyoshi, et al.
Pageof 69